The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end‐stage renal disease and heart failure-Reference-Cited by-同舟云学术

The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end‐stage renal disease and heart failure

Author:

Lin Donna Shu‐Han¹²,Lin Fang‐Ju³⁴⁵,Lin Yu‐Sheng⁶⁷,Lee Jen‐Kuang¹⁸⁹¹⁰¹¹,Lin Yen‐Hung¹⁹¹⁰

Affiliation:

1. Division of Cardiology, Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan

2. Division of Cardiology, Department of Internal Medicine National Taiwan University Hospital, Hsin‐Chu Branch Hsinchu Taiwan

3. School of Pharmacy, College of Medicine National Taiwan University Taipei Taiwan

4. Department of Pharmacy National Taiwan University Hospital Taipei Taiwan

5. Graduate Institute of Clinical Pharmacy, College of Medicine National Taiwan University Taipei Taiwan

6. Division of Cardiology, Department of Internal Medicine Chang Gung Memorial Hospital Chiayi Taiwan

7. College of Medicine, Graduate Institute of Clinical Medical Sciences Chang Gung University Taoyuan City Taiwan

8. Department of Internal Medicine National Taiwan University College of Medicine Taipei Taiwan

9. Department of Laboratory Medicine National Taiwan University College of Medicine Taipei Taiwan

10. Cardiovascular Center National Taiwan University Hospital Taipei Taiwan

11. Telehealth Center National Taiwan University Hospital Taipei Taiwan

Funder

Ministry of Science and Technology, Taiwan

National Taiwan University Hospital

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

Reference52 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What's new in heart failure? June–July 2024;European Journal of Heart Failure;2024-06-28

2. 2024 update in heart failure;ESC Heart Failure;2024-05-28

5. Effects of mineralocorticoid antagonist therapy in heart failure;Pathophysiology, Risk Factors, and Management of Chronic Heart Failure;2024